Results for tag: "Atopic Keratoconjunctivitis Drug"

Atopic Keratoconjunctivitis (AKC) is a chronic, inflammatory eye disorder that affects the cornea and conjunctiva. It is characterized by itching, redness, and tearing of the eyes. Treatment for AKC includes topical corticosteroids, antihistamines, and mast cell stabilizers. In severe cases, immunomodulatory agents may be used. The Atopic Keratoconjunctivitis Drug market is composed of a variety of drugs used to treat the symptoms of AKC. These drugs are typically administered topically, either as eye drops or ointments. They are designed to reduce inflammation, reduce itching, and improve tear production. Some of the companies in the Atopic Keratoconjunctivitis Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more